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Abstract
In this study we generated a novel dual specific phosphatase 4 (DUSP4) deletion mouse using a targeted deletion strategy
in order to examine the role of MAP kinase phosphatase-2 (MKP-2) in immune responses. Lipopolysaccharide (LPS) induced
a rapid, time and concentration-dependent increase in MKP-2 protein expression in bone marrow-derived macrophages
from MKP-2
+/+ but not from MKP-2
2/2 mice. LPS-induced JNK and p38 MAP kinase phosphorylation was significantly
increased and prolonged in MKP-2
2/2 macrophages whilst ERK phosphorylation was unaffected. MKP-2 deletion also
potentiated LPS-stimulated induction of the inflammatory cytokines, IL-6, IL-12p40, TNF-a, and also COX-2 derived PGE2
production. However surprisingly, in MKP-2
2/2 macrophages, there was a marked reduction in LPS or IFNc-induced iNOS
and nitric oxide release and enhanced basal expression of arginase-1, suggesting that MKP-2 may have an additional
regulatory function significant in pathogen-mediated immunity. Indeed, following infection with the intracellular parasite
Leishmania mexicana, MKP-2
2/2 mice displayed increased lesion size and parasite burden, and a significantly modified Th1/
Th2 bias compared with wild-type counterparts. However, there was no intrinsic defect in MKP-2
2/2 T cell function as
measured by anti-CD3 induced IFN-c production. Rather, MKP-2
2/2 bone marrow-derived macrophages were found to be
inherently more susceptible to infection with Leishmania mexicana, an effect reversed following treatment with the arginase
inhibitor nor-NOHA. These findings show for the first time a role for MKP-2 in vivo and demonstrate that MKP-2 may be
essential in orchestrating protection against intracellular infection at the level of the macrophage.
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Introduction
The mitogen-activated protein (MAP) kinase phosphatases
(MKPs) are a family of dual specific phosphatases which regulate
the functional activity of the major MAP kinase subfamilies
through tyrosine and threonine dephosphorylation [1]. At least
eleven isoforms exist each with different structures, subcellular
distributions, substrate specificity and mechanisms of regulation.
For example, the prototypic MKP-1 is induced by a wide variety
of extracellular signals, is strictly nuclear located, and is able to
dephosphorylate all MAP kinases, whereas MKP-3 is constitutively
expressed, cytosolic and selective for extracellular regulated kinase
(ERK) above the other major MAP kinases, c-Jun N-terminal
kinase (JNK) and p38 MAP kinase. Thus, the action of one or
more MKP is essential for the tight regulation of MAP kinase
activity and subsequent functional responses mediated by a vast
array of extracellular stimuli [1].
A number of MKPs have been implicated in the regulation of
disease. Dysfunction or changes in expression of MKPs is a feature
of a number of cancers [1], whilst roles in gluconeogenesis, insulin
resistance and diabetes have also been established [2,3]. Recent
evidence also implicates a role in the regulation of immune
responses [4]. Deletion of MKP-1 [5] and PAC-1 [6] have been
shown to both enhance and reduce LPS mediated cellular
responses respectively, whilst MKP-5 is thought to regulate
adaptive immunity via effects upon T-cells [7]. Furthermore,
one of the main anti-inflammatory effects of dexamethasone is
attributed to the induction of MKP-1 and the subsequent
inhibition of p38 MAP kinase [8].
MAP kinase phosphatase-2 (MKP-2) is a class I DUSP [9],
induced by growth factors, hormones and stress agents such as
hydrogen peroxide. It is nuclear located due to two nuclear
location sequences [10] and dephosphorylates ERK and JNK in
vitro [11] whilst being ineffective for p38 MAP kinase despite
binding strongly to this kinase [12]. Cellular studies suggest the
potential of cell type specificity as stable or conditional over-
expression of MKP-2 selectively inhibits JNK in epithelial cells
types [13,14]. Although often described as a surrogate to MKP-1,
MKP-2 has been demonstrated to have roles in cellular apoptosis
and senescence [13,15]. A number of recent indirect studies have
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function of MKP-2 in the immune system remains uncharacterised
due to the lack of suitable MKP-2 (DUSP-4) knockout mouse
models.
In this study we examined the function of the MKP-2 (DUSP4)
gene using a novel MKP-2 knockout mouse. In macrophages
derived from MKP-2
2/2 mice, we find that its deletion results in
enhanced JNK and p38 MAP kinase activation but not, as
expected, increased ERK phosphorylation. Increased IL-6, IL-12,
TNFa and PGE2 production suggested that MKP-2 may modify
the innate immune response in a manner similar to that observed
in the MKP-1 deletion model. However, in contrast to these
changes we observed marked reduction in inducible nitric oxide
(iNOS) expression and enhanced arginase-1 activation indicative
of an additional regulatory function. We found that that bone-
marrow derived macrophages from MKP-2
2/2 mice were more
susceptible to infection with the intracellular parasite Leishmania
(L.) mexicana than macrophages from their wild-type counterparts.
The enhanced susceptibility of MKP-2
2/2 macrophages was
reversed using the arginase inhibitor nor-NOHA. Consequently
following infection with L. mexicana MKP-2
2/2 mice had limited
ability to control lesion development and parasite growth. This
was related to a significant down-regulation of specific Th1 activity
in MKP-2 deficient mice. Taken together, our results demonstrate
for the first time that MKP-2 plays a functional role in limiting
immune responses associated with the macrophage lineage and
indicates for the first time that MKP-2 is not a functionally
redundant DUSP in vivo.
Results
MKP-2 deletion in macrophages
The MKP-2 deletion strategy is outlined in Figure 1A. Using
targeted homologous recombination exons 2–4 were removed.
Therefore, most of the open reading frame including the
phosphatase catalytic domain and the 39UTR region of the
DUSP4 gene was deleted. Although exon1, which comprises the
59UTR, the start codon and the KIM domain, remained
unchanged, the occurrence of a truncated protein was unlikely
since the poly A tail necessary for any kind of protein synthesis was
removed. Deletion was confirmed by Southern Blotting (insert),
which identified both the wild type 9.9 kB fragment and the
mutated 8.3 kB fragment and by PCR (not shown). In Panels B &
C, bone marrow derived macrophages were assessed for the
presence of MKP-2 protein by Western blotting. In wild type cells,
LPS stimulated MKP-2 expression in a concentration-dependent
manner, giving a maximum response at approximately 1 mg/ml
LPS (Panel B). Induction was also time dependent reaching a peak
at 2 h following LPS treatment (Panel C). No induction was
observed in macrophages derived from MKP-2
2/2 mice.
MKP-2 deletion enhances MAP kinase signalling
We then examined the effect of MKP-2 deletion on LPS-
induced kinase phosphorylation (Figure 2) as MKP-2 has
previously been shown to dephosphorylate ERK and JNK in vitro
[11]. In MKP-2
2/2 macrophages, LPS-stimulated JNK phos-
phorylation was potentiated and prolonged (Panel A *p,0.05).
Enhanced JNK activity was confirmed by JNK in vitro kinase assay
and Western blotting for serine-63 phosphorylation of c-Jun
(Supplementary Figure S1). Surprisingly, LPS-stimulated p38
MAP kinase phosphorylation (Panel B) was also found to be
enhanced in MKP-2
2/2 mice, despite p38 MAP kinase not being
Figure 1. Generation of mice lacking DUSP4/MKP-2 gene by
targeted homologous recombination. (Panel A): Schematic show-
ing the DUSP4/MKP-2 gene locus, the targeted construct and the
resulting targeted allele. Recombination events are indicated by dashed
lines and show the replacement of an 8.3 kb SwaI DUSP4/MKP-2
genomic fragment containing exons 2–4 by the PGK-Neo cassette. SwaI
and HpaI described the restriction sites for the respective enzymes. The
pGK-Neo cassette is flanked by LoxP sites. DTA represents the negative
selection cassette. (Inset) An example of the 39 southern blot analysis of
mouse tail tip genomic DNA following digestion with HpaI using an
external Probe K as indicated in panel A. The autoradiography revealed
the 9.9 kb (wild type) and 8.3 kb (targeted) fragments representing the
two different alleles discriminating wild type, heterozygote or
homozygote mutant animals. B & C: Concentration (LPS mg/ml for
60 min) and time dependent (LPS 100 ng/ml) expression of MKP-2 in
bone marrow derived macrophages. The blot represents at least 4
individual experiments.
doi:10.1371/journal.ppat.1001192.g001
Author Summary
In cells of the immune system are switch-on enzymes
called kinases which regulate responses to infectious
agents such as Leishmania. However, in the same cells
there are switch-off enzymes known as phosphatases
which function to turn off the kinases once they have done
their work. A lot of studies have focussed on the role of
kinases but not phosphatases in response to infection; we
therefore generated a novel mouse in which the gene for
one of these phosphatases, called MKP-2, has been
deleted. We found that in the absence of this phosphatase
unexpected things happened. The profile of inflammatory
proteins, produced by a special cell of the immune system,
called a macrophage, that functions to regulate infection
by Leishmania, changed in ways which meant the
macrophage could either fight infection very effectively
or very weakly. In actual fact, we found that the
macrophages with no MKP-2 fought off Leishmania poorly
and mice deficient in MKP-2 had a modified immune
response favouring the growth of the parasite. This is the
first study to give critical insight into the role of MKP-2 in
fighting Leishmania infection and demonstrates very well
the importance of this class of enzyme in pathogen
biology.
MKP-2 Deletion in Leishmania Infection
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activation was not altered in MKP-2
2/2 macrophages at any time
point studied or over different concentration ranges (Panel C).
Preliminary results, however, showed a lack of ERK translocation
to the nucleus (results not shown) suggesting a lack of access of
ERK to the phosphatase rather than a lack of MKP-2 activity on
ERK as the explanation for this finding.
Cytokine induction modified in MKP-2 knockout
macrophages
Having established that enhanced kinase activation occurred in
macrophages from MKP-2
2/2 mice, we also assessed the
consequences of MKP-2 deletion on the expression and release
of key cytokines, known to be regulated by MAP kinase activation.
Figure 3 shows cytokine production in macrophages derived from
both wild type and MKP-2
2/2 mice. Panel A shows that LPS
induced a substantial increase in IL-6 production manifest at 6–
8 h and reaching a peak after 24 h. MKP-2 deletion had little
effect upon basal levels, however, but markedly enhanced the rate
and magnitude of production stimulated by LPS (24 hr: MKP-2
+/+
=1.8360.01 ng/ml, MKP-2
2/2=4.4460.83 n=4, P,.005).
Similar results were observed for both IL-12, which was assayed
as IL-12p40/70 (Panel B), and TNFa (Panel C) although
production reached a peak at 48 h and the degree of potentiation,
whilst significant, was less than that for IL-6. In contrast, LPS
stimulated IL-10 production was markedly reduced in MKP-2
deficient macrophages (Panel D).
Reciprocal effects upon iNOS and arginase-1 following
MKP-2 deletion
We then assessed the expression of a number of inflammatory
proteins following MKP-2 deletion (Figure 4). Panel A shows that
in MKP-2
2/2 macrophages the rate of onset of cyclo-oxygenase-2
(COX-2) expression was increased in response to LPS, relative to
wild type controls, an outcome predicted by previous studies
assessing MAP kinase regulation of COX-2 expression and
consistent with enhanced JNK and p38 MAP kinase activation.
A difference in induction was observed as early as 2 and 4 h and
was consistent with increased PGE2 production (Panel A and
histogram D). We also assayed inducible nitric oxide synthase
(iNOS) expression following incubation with LPS for up to 24 h.
However, rather than being enhanced, iNOS expression was
strongly inhibited relative to wild type controls and this was
reflected in reduced formation of nitric oxide - derived nitrate and
nitrite (Figure 4, Panel B and histogram E). This strong inhibitory
effect was reproduced when IFN-c was used to induce iNOS
instead of LPS (Supplementary Figure S2). IFN-c is known to
regulate iNOS expression via the JAK/STAT pathway but no
differences where found in the activation of these intermediates in
MKP-2
+/+ and MKP-2
2/2 macrophages (Supplementary Figure
S2). We also determined if other macrophage proteins were down
regulated to a similar extent, specifically arginase-1, a protein
stimulated through the alternative macrophage activation pathway
and utilising the same substrate, L-arginine, as iNOS (Panel C).
Basal arginase-1 expression and activity was considerably higher in
MKP-2
2/2 macrophages, and equivalent to 24 h of IL-4
stimulation in MKP-2
+/+ samples (Panel C and histogram F).
These results contrasted greatly with the expression of iNOS,
which is indicative of classical macrophage activation and shows
that the MKP-2
2/2 macrophages intrinsically have a unique
profile of inflammatory protein expression.
MKP-2 deficiency results in increased susceptibility to
Leishmania mexicana infection
Changes in MAP kinase signalling and iNOS activity are
implicated in the ability of mice to resist infection with Leishmania
[17,18,19,20,21,22]. However, while the signalling and associated
cytokine changes in MKP2
2/2 mice would favour increased
protection, the unexpected changes in iNOS and arginase
expression would favour disease progression. As L. mexicana
induces an intermediate disease phenotype in C57BL/6 and
B6/129 mice whereby lesion growth is controlled, but fails to heal
[23], we used this pathogen to test the ultimate influence of MKP-
2 on disease outcome.
Initially, we tested the effect of Leishmania mexicana promastigotes
on cellular MAP kinase signalling responses and iNOS induction
(Figure 5) to confirm that both LPS, via TLR-4, and promastigotes
mediate common kinase signalling cassettes and related functional
Figure 2. MKP-2 deletion enhances LPS -stimulated MAP kinase
phosphorylation in macrophages. Cells were incubated with LPS
(100 ng/ml) for the indicated time and whole cell lysates were
prepared, and assessed for JNK (Panel A), p38 MAP kinase (Panel B)
or ERK (Panel C) phosphorylation or total levels by Western blotting as
outlined in the Methods section. Each blot is representative of 4
individual experiments. * P,0.05 relative to MKP-2
+/+ macrophages.
doi:10.1371/journal.ppat.1001192.g002
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promastigotes activated ERK, JNK and p38 MAP kinase (Panel
A). However, in TLR-4 deficient macrophages, both ERK and
JNK phosphorylation were abolished in response to promastigotes,
with a substantial reduction in p38 MAP kinase. In TLR-4
2/2
macrophages the LPS-induced responses were also reduced, but
this not by as much as the reduction seen in promastigote-induced
responses. This is probably because our commercial source of LPS
may have been contaminated with bacterial lipoproteins resulting
in some activation of TLR-2. Nevertheless, these data suggest that
both agents act principally through TLR-4. MKP-2 deletion had
little effect upon the ERK response (Panel B) or p38 MAP kinase
signalling (not shown) in response to promastigotes and JNK
phosphorylation was only marginally increased although not
significantly (Panel C). Despite activation of these kinases,
promastigotes alone failed to significantly induce MKP-2 protein
(data not shown) and had no effect upon iNOS synthesis alone or
in response to LPS (Panel D). Furthermore, promastigotes did not
significantly increase the already high levels of arginase-1 activity
in MKP-2
2/2 macrophages (arginase activity, mg/ml: MKP-2
+/+
control=125.4614.3, L. mexicana=101.1613.0; MKP-2
2/2 con-
trol=345.8617.10, L. mexicana=392623.5 n=3).
Nevertheless, despite promastigotes being unable to modify
MKP-2 expression per se, we found that MKP-2 deletion had a
significant effect in vivo following Leishmania mexicana infection.
Upon injection into the footpad with L. mexicana, MKP-2
2/2 mice
developed progressively growing lesions and could not limit lesion
growth unlike their wild-type counterparts (Figure 6A). Lesions
grew more rapidly in MKP-2
+/+ mice compared with MKP-2
2/2
mice in the first 4 weeks of infection but the parasite burdens
remained higher at this site in MKP-2
2/2 mice than their wild-
type counterparts throughout infection (Figure 6B). At week 15,
the Th1 response, as measured by antigen specific IgG2a and IFN-
c production (Figures 7A and B), was significantly reduced in
MKP-2
2/2 compared with MKP-2
+/+ mice confirming that the
MKP-2
2/2 mice were defective in their ability to control parasite
growth. No differences in the Th2 response were noted with
specific IgG1 (Figure 7A) and whole IgE as well as IL-4, IL-13,
and IL-10 production (data not shown), all being similar in MKP-
2
2/2 and MKP-2
+/+ mice. There was no evidence of an intrinsic
T cell defect in MKP-2
2/2 mice as splenocytes from infected
MKP-2
2/2 and MKP-2
+/+ mice produced similar levels of IFN-c
upon stimulation with anti-CD3 (Figure 7C).
The growth of L. mexicana is subject to different immunological
controls at different sites. The non-healing response to L. mexicana in
infected footpads is associated with deficient IFN-c production,
independent of a Th2 response, whereas in the back rump the host
response to infection is entirely Th2 dependent [24]. Consequently,
we monitored the growth of L. mexicana in the shaven back rump of
MKP-2
2/2 and MKP-2
+/+ mice (Figure 8). Lesions appeared
earlier and lesion growth was more rapid in MKP-2
2/2 mice
(Figure 8A). The increased susceptibility of MKP-2
2/2 mice over
wild-type animals was associated with expanded Th2 responses in
these animals as measured by significantly increased specific IgG1
production (Figure 8B) and increased ConA induced splenocyte IL-
4 (Figure 8D) and IL-13 (Figure 8E) production. At the same time
there were no significant differences between infected MKP-2
2/2
and MKP-2
+/+ in IFN-c production (Figure 8C) and specific IgG2a
levels(Figure 8B). As with footpadinfections there was no indication
of an intrinsic T cell defect as measured by anti-CD3 splenocyte
cytokine production (results not shown).
MKP-2 deficient bone marrow-derived macrophages
have impaired ability to control the growth of L.
mexicana
To confirm that the intrinsic defect in infectivity was at the level
of the host macrophage we therefore compared the growth of L.
mexicana parasites in MKP-2
2/2 and MKP-2
+/+ bone marrow
derived macrophages. Macrophages were infected with promas-
tigotes at a multiplicity of infection (M.O.I) of 5 parasites/
macrophage and growth monitored at 4, 24, 48 and 72 h post-
Figure 3. Cytokine production in macrophages derived from MKP-2
2/2 mice. Cells were stimulated with LPS (100 ng/ml) for the indicated
times and supernatants assessed for either IL-6 (panel A), IL-12 (Panel B), TNFa (Panel C) or IL-10 (Panel D) as outlined in the Methods section. Each
value represents the mean 6 SEM from at least 4 individual experiments. * P,0.05 compared to MKP-2
+/+ macrophages.
doi:10.1371/journal.ppat.1001192.g003
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(Figure 9). Macrophages from MKP-2
2/2 mice were significantly
more permissive to infection than MKP-2
+/+ macrophages as
measured by the percentage of cells infected by 4 h (p,0.01)
(Figure 9A). Similarly, parasite growth was significantly enhanced
in MKP2
2/2 macrophages compared with MKP-2
+/+ macro-
phages under non-stimulated conditions up to 72 h post-infection
(Figure 9B). MKP-2
2/2 macrophages were, however, able to
control parasite growth following IFN- c+LPS stimulation
although only to a level comparable with non-stimulated
macrophages derived from MKP-2
+/+ bone marrow. This would
be consistent with data in figure 5 showing that after 48 h there is
measurable iNOS expressed in MKP-2
2/2 KO macrophages in
response to LPS although much less than in MKP-2
+/+
macrophages.
L-arginine inhibition reverses the effect of MKP-2
deficiency on parasite growth
Figure 10 shows the effect upon NO production and parasite
infection following the treatment with the arginase inhibitor N
v-
hydroxy-nor-Arginine (nor-NOHA). Initially, we assessed NO
release to confirm that arginase inhibition had been effective in
altering, as predicted, the levels of NO in macrophages (Panel A).
In LPS+IFN-c -stimulated MKP-2
2/2 macrophages NO levels
were, as predicted, low, however following nor-NOHA treatment,
levels increased significantly equivalent to the level observed for
wild type macrophages. In addition, treatment of MKP-2
+/+
macrophages with nor-NOHA failed to significantly increase
the levels of NO further. When assessing parasite growth in
MKP-2
2/2 and MKP-2
+/+ macrophages following nor-NOHA
pre-treatment we found that changes in arginase activity altered
infectivity (Panel B). In MKP-2
2/2 macrophages, infectivity was
high relative to wild type as expected. However, infectivity was
significantly reduced in response to nor-NOHA, to a level which
was not significantly different from MKP-2
+/+ macrophages.
Inhibition of NO using L-NAME also increased the infectivity of
the parasite in MKP-2
+/+ macrophages suggesting NO is a
determinant of macrophage resistance to infectivity with L.
Mexicana promastigotes. Furthermore, L-NAME treatment of
infected MKP-2
2/2 macrophages resulted in rapid macrophage
Figure 4. Differential effects of MKP-2 deletion upon COX-2, iNOS and Arginase-1 expression in LPS-stimulated macrophages. Cells
were stimulated with LPS (100 ng/ml) for the indicated times and whole cell lysates were prepared, and assessed for COX-2 (Panel A), iNOS (Panel B)
and Arginase-1 (Panel C) by Western blotting as outlined in Materials and Methods. Blot is representative of three individual experiments. Samples
were assessed for associated PGE2 histogram (D), Nitrite (E) and arginase activity (F).
doi:10.1371/journal.ppat.1001192.g004
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to quantify changes in infectivity. This finding nevertheless re-
enforced the idea of increased sensitivity of MKP-2
2/2 macro-
phages to infection per se.
Discussion
This study demonstrates for the first time a novel immune
function for MKP-2 in vivo primarily caused by changes in the
ability of macrophages to induce innate immune responses. In
particular, MKP-2 deletion gives rise to a novel phenotype
associated with decreased iNOS and increased arginase-1 activity
which makes MKP-2 deficient macrophages more intrinsically
susceptible to infection with the intracellular parasite L. mexicana.
Infection of MKP-2 deficient mice not only results in increased
disease susceptibility and parasite growth in vivo compared to their
wild-type counterparts but it is also associated with either
inhibition of a Th1 response or promotion of a Th2 response
appropriate to enhance infection at the site utilised.
In characterising the novel MKP-2
2/2 model, we clearly
demonstrate that following gene deletion JNK phosphorylation
and activity was enhanced. This is consistent with the original
studies in vitro [11] and more recent studies using either stable or
conditional expression of MKP-2 [13,14]. ERK activation was,
however, not enhanced in MKP-2
2/2 macrophages despite being
a substrate for MKP-2, due to compartmentalisation of ERK to
the cytosol, generating a substrate selective function for MKP-2 in
this cell type. Unexpectedly, we found that phosphorylation of p38
MAP kinase was also enhanced despite this kinase not being
Figure 5. Macrophage activation by Leishmania mexicana. In
Panel A macrophages from wild type (WT) and TLR-4 deletion mice
(TLR-4
2/2) were incubated with LPS (100 ng/ml) or promastigotes (5:1)
for30 min. InpanelsB andC,MKP-2
+/+ macrophages (+/+) andMKP-2
2/2
(2/2) were stimulated with promastigotes for the times indicated. In
Panel D cells were incubated promatigotes alone or in combination with
LPS for 48 h. Samples were assessed for ERK, JNK and p38 MAP kinase
phosphorylation or iNOS expression as indicated. Each blot is represen-
tative of three individual experiments.
doi:10.1371/journal.ppat.1001192.g005
Figure 6. MKP-2 deficiency increases susceptibility to L.
mexicana infection in the footpad. Infection was with 5610
6 L.
mexicana stationary phase promastigotes into the footpad and
susceptibility was measured by mean 6 SEM lesion growth (Panel A),
and parasite burdens (***p,0.001) (Panel B). MKP-2
2/2 (n=8), unlike
MKP-2
+/+ mice (n=7) were unable to control lesion growth (Panel A)
and this was reflected in the comparative parasite burdens (Panel B) in
the footpad. Representative results from 3 similar experiments.
doi:10.1371/journal.ppat.1001192.g006
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cellular study, however, has indirectly implicated involvement of
MKP-2 in regulating AMP kinase and p38 MAP kinase-dependent
gluconeogenesis [25] and our findings support this data. Our data
show that predictions based on in vitro data can be misleading and
indeed study of other MKP deletion mice also shows discordance
between substrate specificity in vitro and kinase regulation in whole
cells. Whilst MKP-1 is effective against all three major MAP
kinases, enhanced p38 MAP kinase is observed in MKP-1
2/2
macrophages [26], whilst in cells derived from PAC-1 knockout
mice, ERK phosphorylation is inhibited despite ERK being a
specific substrate for PAC-1 in vitro [6].
Our studies demonstrated that enhanced JNK and p38 MAP
kinase activation where reflected at the level of cytokine synthesis.
Evidence strongly supports a role for p38 MAP kinase in the
expression of IL-6, TNFa and IL-12 [27,28,29]. In contrast, a role
for JNK is less well defined and cell type specific involvement is
implicated [27,29]. Our studies also correlate well with those
obtained with the MKP-1 deletion which implicates p38 MAP
kinase as the main in vivo substrate for MKP-1 and shows this
kinase to be linked to cytokine release [26,30]. This would suggest
that MKP-2 deletion, in a manner similar to MKP-1 [26,30] could
enhance innate immune responses in vitro and also possibly in vivo.
This possibility was contradicted by other findings. Whilst we
found up regulation of COX-2 and associated PGE2 in MKP-2
deletion mice, results also observed in MKP-1 deletion mice,
surprisingly expression of iNOS was ablated. Studies show that
iNOS expression is enhanced following MKP-1 deletion in vitro
[31] and associated with increased mortality in vivo [32]. This
suggests the potential for MKP-2 deletion, unlike ablation of
MKP-1, to protect against NO induced mortality. Furthermore,
we find that basal arginase 1 expression and associated arginase
activity is markedly increased in MKP-2 deletion mice, a response
which would also mediate a reduction in NO formation, this is
again different to the findings in MKP-1
2/2 macrophages [31].
The molecular mechanisms underpinning the reciprocal regula-
tion of these two inflammatory proteins are at present unclear, as
none of the cognate signalling pathways regulating iNOS or
arginase induction were found to be negatively affected. Thus,
there is a potential for a direct action of MKP-2 within the nucleus
which may directly regulate transcription. Recently, MKP-1 has
been implicated in the regulation of histone phosphorylation in the
nucleus [33] suggesting nuclear functions for the MKPs other than
direct MAP kinase regulation.
Overall our studies in vitro therefore reveal that in the absence of
MKP-2 macrophages take on a functional profile which can be
directed towards either a type-1 or type-2 phenotype. Our in vivo
studies enabled us to demonstrate which of these profiles
predominate in vivo. Leishmania infection has a well recognized
abilitytosubvert the developmentofTh1responsespartlyvia effects
upon MAP kinase signalling [17,20,34]. Most of these studies have
implicated MAP kinase involvement at the level of the host
macrophage ordendritic cell, butJNKactivation viaT cellshasalso
been shown to negatively regulate Th2 cells [34] in a healing
response. Therefore, we hypothesised, given the enhanced p38 and
JNK activation of MPK-2
2/2 mice on the C57BL/6 background,
that such animals would develop a healing phenotype against this
organism. MKP-2 negatively regulated IL-12, IL-6 and TNF-a
expression andpositively regulatesIL-10 confirming this hypothesis.
Currently iNOS induction and the subsequent release of NO is
considered protective against intracellular infection with many
organisms including Leishmania species [19]. In addition, arginase-1,
which competes for the same substrate as iNOS, has been shown to
promote disease progression not only against Leishmania (in both
healing and non-healing strains of mice [18]), but also Mycobacterium
and Toxoplasma gondii [35]. As MKP-2 deficiency downregulates
iNOS, but upregulates arginase-1 expression and activity this
suggests that, counter intuitively, MKP-2
2/2 animals would be
more susceptible to Leishmania infection.
Our studies indeed show that MKP2
2/2 mice are, in fact, more
susceptible to infection with L. mexicana and it is the consequence of
changes in iNOS and arginase rather than changes in kinase
mediated inflammatory cytokine signalling which dictates the
subsequent in vivo response to MKP-2 deletion. The differential
effects of Leishmania infection in MKP-2
2/2 macrophages relative
to MKP-2
+/+ is not due to Leishmania interacting with the cell in a
different way to LPS, both agents utilised TLR-4 during the early
stages of stimulation. Furthermore, the fact that Leishmania mexicana
alone does not induce MKP-2 points to another potentially
indirect effect of MKP-2 deletion not linked to changes in kinase
activity. Nevertheless, following footpad infection with L. mexicana,
lesion growth was increased and parasite burden enhanced,
outcomes associated with reduced IFN-c production. Of signifi-
cance it has recently been demonstrated that during L. major
infections high local arginase levels at the site of infection mediate
L-arginine depletion, which results in impaired local CD4
+ T cell
function particularly IFN-c production [21,22]. The importance
of arginase in modulating the virulence of L. mexicana is also
highlighted by the fact that arginase null-mutant L. mexicana has
attenuated virulence in vitro and in vivo suggesting that the parasite
arginase depletes host L-arginine available for iNOS activity
[36,37]. Significantly, mice infected in the footpad with arginase
null-mutant L. mexicana have increased antigen induced IFN- c
production. Thus changes in arginase-1 expression in MKP-2
2/2
Figure 7. MKP-2 deficiency results in a limited Th1 response
following footpad infection with L. mexicana. Th1 responses were
measured by specific serum IgG2a antibody (*p,0.05) (Panel A), and
antigen induced splenocyte IFN-c production (**p,0.01) (Panel
B).Results are expressed as mean 6 SEM of MKP-2
2/2 (n=8) and
MKP-2
+/+ (n=7) mice. MKP-2 deficiency did not directly impair the
ability of T cells to mount a Th1 response as anti-CD3 stimulation of
splenocytes from both infected and non-infected MKP-2
+/+ and MKP-
2
2/2 mice induced similar IFN-c production (Panel C). Representative
results from 3 similar experiments.
doi:10.1371/journal.ppat.1001192.g007
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and immune responses.
Our study is one of the first to reveal an in vivo function for
MKP-2 and indicates that MKP-2 does not act as a surrogate to
the more extensively studied MKP-1. Our results reveal the
potential of MKP-2 to participate in opposing regulatory
mechanisms. The first mechanism is based on upregulation of
JNK and p38 MAP kinase signalling and is associated with
enhanced cytokine expression. The second regulatory mechanism
however, involves changes in iNOS and arginase-1 expression,
associated with the alternative activated macrophage pathway, is
not readily associated with modulation in kinase signalling but
possibly involves a different molecular target. The in vivo
consequences of this second action can be clearly seen during
Leishmania infection where there is down-regulation of Th1 and/or
up-regulation of Th2 responses, distinguishing MKP-2 from any of
the other MKPs believed to play a role in immune function.
Materials and Methods
Ethics statement
All animal procedures conformed to guidelines from The Home
Office of the UK government. All work was covered by two Home
Office licences: PPL60/3929, ‘‘mechanism of control of parasite
infection’’ and PPL60/3439, ‘‘genetic models of cancer and
inflammation’’.
Materials
Dulbecco’s modified Eagle’s medium and foetal calf serum
(FCS) were purchased from Invitrogen. RPMI 164 and LPS were
from Sigma Aldrich. Antibodies against p-ERK, and MKP-2 were
obtained from Santa Cruz. All other phospho-antibodies were
purchased from Biosource International Inc. (USA) and secondary
antibodies from Jackson Immuno Research Laboratories Inc (PA,
USA). The TLR-4 deficient mice were obtained from Professor
Akira S. Osaka University, Japan.
Methods
Generation of MKP-2 deficient mice. The deletion of the
MKP-2 gene was performed in collaboration with Genoway,
Lyon, France using standard procedures. The short arm and the
long arm flanking both side of the cluster of exon 2–4 of the mouse
MKP-2 gene was obtained by PCR using the following primers:
for the small homology arm: 59-GTGCCTGGTTCTGTGTGT-
GTCTGTTCTCC-39 for the forward primer and 59-TCTTACA-
GCCCTCTTTCCTCACGGTCG-39 for the reverse primer
Figure 8. MKP-2 deficiency results in increased susceptibility and an enhanced Th2 response following infection in the rump with L.
mexicana. Lesions developed quicker and were of greater size in MKP-2
2/2 (n=6) mice compared with MKP-2
+/+ (n=6) mice (Panel A). Enhanced Th2
responses in MKP-2
2/2 mice were measured by increased specific serum IgG1 antibody production compared with wild-type counterparts
(**p,0.01) (Panel B). In addition while ConA induced splenocyte IFN-c production was similar in MKP2
2/2 and MKP-2
+/+ mice (Panel C), IL-4 (*p,0.05)
(Panel D) and IL-13 (***p,0.001) (Panel E) levels were significantly elevated in MKP-2
2/2 animals. Results are expressed as mean 6 SEM of MKP-2
2/2
and MKP-2
+/+ mice.
doi:10.1371/journal.ppat.1001192.g008
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arm: 59-CTTTAGGAGCGACGGCCAGGAACACAGG-39for
the forward primer and 59-ACCCTGCCACACAGGTTGG-
AGCAAGG-39 for the reverse primer producing a PCR
fragment of 6336 bp. Both arms were introduced into a PBS
vector in either side of the neomycin cassette. The final vector was
transfected into 129Sv mouse embryonic stem cell. Selection was
made to select only the clones which had homologous
recombination events first by PCR and then using Southern
blotting for the short and the long arm on the construct. Male
chimeras were obtained and crossed with C57Bl/6 female to
obtain the F1 generation. The F1 generation was screened for
germ line transmission of the mutation. Heterozygous mice were
backcrossed against C57Bl/6 and genotyped using Southern
blotting and PCR.
Generation of mouse macrophages. Bone marrow derived
macrophages were isolated from femurs of 3 months old MKP-2
2/2
or
+/+ mice and grown in DMEM, containing 20% (v/v) heat-
inactivated FCS supplemented and 30% L cell-conditioned
medium supplemented with 5 mM L-Glutamine, 100 U/ml
penicillin, 1 mg/ml streptomycin. Adherent cells were harvested
and then seeded in either 12 well (1610
6 cells/ml) or 96 well (2610
6
or 2610
5 cells/ml) plates with RPMI 1641 supplemented with 10%
FCS.
Western blotting. Proteins (15 mg per lane) were separated
by 10% SDS-PAGE and transferred onto nitrocellulose. The
membranes were blocked for non-specific binding for 2 h in 2%
BSA (w/v) diluted in NATT buffer 50 mM Tris-HCl, 150 mM
NaCl, 0.2% (v/v) Tween-20. The blots were then incubated
overnight with 50 ng/ml primary antibody diluted in 0.2% BSA
(w/v) in NATT buffer. The blots were washed with NATT buffer
for 90 min and incubated with HRP-conjugated secondary
antibody (20 ng/ml in 0.2% BSA (w/v) diluted in NaTT buffer)
for 2 h. After a further 90 min wash, the blots were subjected to
ECL reagent and exposed to Kodak X-ray film.
Figure 9. MKP-2 deficiency results in impaired ability of
macrophages to control L. mexicana infection. Both the percent-
age of infected macrophages (p,0.005) (Panel A) and the numbers of
parasites/infected macrophage (p,0.01) (Panel B) were significantly
greater in non-stimulated bone marrow derived-macrophages from
MKP2
2/2 donors compared with MKP-2
+/+ mice by 72 h post-infection.
While stimulation with 100 ng LPS + 100U IFN-c significantly inhibited
both the percentage (Panel A) of infected macrophages and the mean
number of parasites/infected macrophage (Panel B) in the cultures
derived from MKP-2
2/2 mice compared with non-stimulated MKP-2
2/2
macrophages this was only to levels comparable with those found in
non-stimulated macrophages from MKP-2
+/+ mice at 72 h post-
infection. Each figure represents 3 experiments (mean 6 SEM of
triplicate determinations).
doi:10.1371/journal.ppat.1001192.g009 Figure 10. Arginase inhibition reverses the susceptibility of
MKP-2
2/2 macrophages to control L. mexicana infection.
Macrophages were pre-treated with or without inhibitors for 60 min
as indicated prior to activation with LPS (100 ng/ml) plus IFN-c (100 U/
ml) and samples assayed for NO after 48 hr (Panel A). In panel B
following treatment with inhibitors macrophages were incubated with
L. mexicana promastigotes (5:1) and survival measured after 48 h as
outlined in the Material and Methods section. Data is displayed as a
composite of the number of parasites per cell and the percentage of
infected cells.Results are expressed as mean 6 SEM. *P,0.05 compared
to vehicle treated cells (RPMI).
doi:10.1371/journal.ppat.1001192.g010
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mexicana (MYNC/BZ/62/M379) was maintained by serial passage
of amastigotes inoculated into the shaven rumps of BALB/c mice.
Infections were initiated using stationary phase promastigotes
grown in TC100 insect medium (Sigma, St. Louis, USA)
supplemented with v/v 10% FCS (Harlan Sera-Lab Ltd.,
Crawley). Promastigotes (5610
6 in 25 ml) were inoculated
subcutaneously into the hind footpad or subcutaneously into the
shaven back rump. Female 6–8 week old MKP-2
2/2 and MKP-
2
+/+ mice were used in each experiment. Increase in footpad size
was measured using a dial gauge micrometer and rumps with a
slide gauge micrometer at weekly intervals. Parasites were
enumerated from lesions as previously described [23].
Macrophage infection with L. mexicana promastigotes.
One hundred microlitres of bone marrow-derived MKP-2
2/2 or
MKP-2
+/+ macrophages (2610
6/ml) in RPMI 1641 supplemented
with 10% FCS were added to each well of a 24-well tissue culture
plate (Techno Plastic Products, Trasadingen, Switzerland)
containing round 13-mm cover slips. Cells were infected by
adding 100 ml L. mexicana stationary phase promastigotes at a
parasite: host cell ratio of 5: 1 and incubating the cells for 4 h at
33uC The medium was then changed to remove unattached
parasites and replenished with 100 ml fresh medium or medium
containing IFN-c or LPS alone or in combination. Cells were fixed
in methanol (Banford Laboratories, Norden Rochdale, UK) and
stained with 10% (v/v) aqueous Giemsa stain (BDH Laboratory
Supplies) at 4, 24, 48 and 72 h post infection so that the
percentage of cells infected and the number of parasites/100
infected macrophages could be determined by microscopy. To
inhibit arginase or iNOS activity, cells were pre-treated for 1 h
with 50 mMN
v-hydroxy-nor-Arginine (nor-NOHA, Calbiochem)
or 5 mM N (G)-nitro-L- arginine methyl ester (L-NAME, Sigma),
respectively. L. mexicana promastigotes were added at an M.O.I. of
5 and plates were incubated at 34uC. After 48 h, medium was
removed, cells fixed with methanol and subsequently stained with
Giemsa. Coverslips were mounted onto microscopic glass slides
and parasite number and infection rate for a total of 200
macrophages per coverslip was assessed using a bright field
microscope.
Immunological analysis. ELISA was routinely used for
detection of IL-6, IL-12, TNFa and PGE2 in macrophages and L.
mexicana specific-IgG1 and -IgG2a and total IgE in the plasma of
infected mice as previously described [38]. Splenocytes were
cultured in 96-well plates as previously described [39] and IFN-c,
IL-10, IL-13 and IL-4 production measured by capture ELISA.
Measurement of arginase activity. Arginase activity was
measured using an assay based on a reaction with a-
isonitrosopropiophenon (ISPF). Briefly, macrophages were grown
on 24- well plates, exposed to agonist as appropriate and harvested
in 50 ml lysis buffer (50 mM Tris-HCl, 10 mM MnCl2,0 ?1%
Triton X-100, 5 mg/ml pepstatin A, 5 mg/ml aprotinin, and 5 mg/
ml antipain hydrochloride, pH 7.4). Arginine hydrolysis was
carried out by incubating cell lysates with 25 mlo f0 ?5ML -
arginine (pH 9.7) at 37uC for 60 min. The reaction was
terminated by adding 400 mL of an acid solution (H2SO4,
H3PO4 and H2O in a ratio of 1:3:7 and 25 mL of a 9% solution
of ISPF). Samples along with known urea standards were
incubated at 95uC for 45 minutes, and then allowed to cool for
10 min in the dark. Aliquots were added to wells of a 96 well plate
and absorbance read at 540 nm on a Spectromax 190 plate
reader.
NO measurement in cell culture supernatants. Cell
culture medium supernatant was collected and nitrite was analysed
as a measure for NO production using the Griess reagent. Equal
volumes of Griess reagent (1% (w/v) sulphanilamide/ 0.1% (w/v) N-
(1-naphtyl)ethylenediamine dihydrochloride/ 2.5% (v/v) H3PO4)
and cell culture supernatant were mixed and incubated at room
temperature in the dark for 10 min. Absorbance was read at 540 nm
on a Spectromax 190 plate reader. Nitrite production was
determined using NaNO2 as standard.
Statistical analysis. Statistical significance was determined
between groups using the Mann-Whitney U test for endpoint
antibody titrations, as well as Student’s t-test and one-way
ANOVA with Dunnett’s post test where appropriate. All
experiments were performed at least three times with similar
findings.
Supporting Information
Figure S1 MKP-2 deletion enhances LPS-stimulated JNK
activation and c-Jun phosphorylation in mouse bone marrow
macrophages. Macrophages from MKP-2
+/+ (open bars) and
MKP-2
2/2 (closed bars) mice were incubated with LPS (100ng/
ml) for the indicated times and whole cell lysates prepared and
assessed for JNK activity by in vitro kinase assay (Panel A) and p-c-
Jun and c-Jun content (Panel B) by Western blotting. Each blot is
representative of at three individual experiments. Each quantified
value is expressed as mean 6 SEM.
Found at: doi:10.1371/journal.ppat.1001192.s001 (3.44 MB TIF)
Figure S2 IFNc -stimulated iNOS induction is severely ablated
in MKP-2 deficient macrophages but not due to JAK/STAT
pathway disruption. Macrophages from MKP-2
+/+ (+/+) or MKP-
2
2/2 (2/2) mice were challenged with IFN-c for the indicated
times. iNOS expression (Panel A) and phosphorylation of JAK
(Panel B) and STAT (Panel C) were assessed by Western blotting.
Each blot is representative of at three individual experiments.
Each quantified value is expressed as mean 6 SEM.
Found at: doi:10.1371/journal.ppat.1001192.s002 (4.86 MB TIF)
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